Cargando…
The Art of Oncology: COVID‐19 Era
Autores principales: | Reynolds, Kerry L., Klempner, Samuel J., Parikh, Aparna, Hochberg, Ephraim P., Michaelson, M. Dror, Mooradian, Meghan J., Lee, Richard J., Soumerai, Tara E., Hobbs, Gabriela, Piotrowska, Zofia, Sykes, David B., Farago, Anna F., Bardia, Aditya, Rosovsky, Rachel P., Ryan, David P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405267/ https://www.ncbi.nlm.nih.gov/pubmed/32697887 http://dx.doi.org/10.1634/theoncologist.2020-0512 |
Ejemplares similares
-
Temporal Trends in Inpatient Oncology Census Before and During the COVID‐19 Pandemic and Rates of Nosocomial COVID‐19 Among Patients with Cancer at a Large Academic Center
por: Zubiri, Leyre, et al.
Publicado: (2021) -
Precision medicine and personalized breast cancer: combination pertuzumab therapy
por: Reynolds, Kerry, et al.
Publicado: (2014) -
Case Report: Fulminant Celiac Disease With Combination Immune Checkpoint Therapy
por: Falade, Ayo S., et al.
Publicado: (2022) -
Cost-effectiveness of Atezolizumab Combination Therapy for First-Line Treatment of Metastatic Nonsquamous Non–Small Cell Lung Cancer in the United States
por: Criss, Steven D., et al.
Publicado: (2019) -
Coronavirus Disease 2019 Infection in a Patient Population with Lung Cancer: Incidence, Presentation, and Alternative Diagnostic Considerations
por: Piper-Vallillo, Andrew J., et al.
Publicado: (2020)